Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Share-based Compensation (2019 - 2025)

Volitionrx (VNRX) has disclosed Share-based Compensation for 9 consecutive years, with $812045.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Share-based Compensation rose 290.32% year-over-year to $812045.0, compared with a TTM value of $1.2 million through Jun 2025, down 27.78%, and an annual FY2024 reading of $527940.0, down 76.94% over the prior year.
  • Share-based Compensation was $812045.0 for Q2 2025 at Volitionrx, up from $451374.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $915031.0 in Q1 2022 and bottomed at -$414865.0 in Q4 2024.
  • Average Share-based Compensation over 5 years is $495206.7, with a median of $546661.0 recorded in 2021.
  • The sharpest move saw Share-based Compensation surged 1143.81% in 2022, then tumbled 189.08% in 2024.
  • Year by year, Share-based Compensation stood at $56781.0 in 2021, then soared by 1143.81% to $706249.0 in 2022, then plummeted by 34.06% to $465734.0 in 2023, then crashed by 189.08% to -$414865.0 in 2024, then skyrocketed by 295.74% to $812045.0 in 2025.
  • Business Quant data shows Share-based Compensation for VNRX at $812045.0 in Q2 2025, $451374.0 in Q1 2025, and -$414865.0 in Q4 2024.